CTLA4 and breast cancer: Importantly, T-reg cells with elevated CTLA-4, PD-L1, and TNFR2 expression seem to have a highly immunosuppressive phenotype in the BC TME; functional elimination or activity reversal of these cells could provide a promising treatment strategy for BC.